ArticleDrugs & aging2026
Out-of-Pocket Healthcare Expenditures Associated with Prescription Opioid Use in Older Adults with Non-cancer Chronic Pain.
Article in Drugs & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChronic pain is a long-term illness impacting quality of life in older adults, and while opioids are frequently used to manage chronic pain in all adults, there is increased risk of medical complications in older adults stemming from opioid therapy. Therefore, we aimed to examine the relationship of prescription opioids on out-of-pocket (OOP) healthcare expenditures in a cohort of older adults (≥ 50 years) with chronic pain in the United States (US).
methodsOur analysis used data from the Health and Retirement Study, a longitudinal cohort study capturing health and lifestyle information of older adults living in the US. We employed multivariable Poisson regression with fixed effects to model how OOP expenditures change when older adults start and discontinue opioids.
resultsOur sample had 7295 unique respondents with 20,738 eligible interviews. The median total OOP expenditures were higher in respondents using opioids compared to years when respondents were not (US $396 vs $308; p = 0.001). On fixed-effects Poisson regression analysis, prescription opioid use was associated with higher OOP expenditures for hospitalizations (p < 0.001), doctor/clinic visits (p < 0.001), and nursing home care (p < 0.001), but not total OOP expenditures (p = 0.314).
conclusionsPrescription opioid use is associated with increased OOP expenditures relating to inpatient, outpatient, and long-term care, suggesting that prescription opioids may not directly translate to increased prescription expenditures but indicate a period of increased healthcare vulnerability for older adults.
Indexed as
Identifiers
41779287What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.